Crowdonomics
All companies

Autonomix Medical, Inc.

Public

Healthcare · The Woodlands, TX

Estimated pre-money ⓘ
$61.7M
As of Jul 2023 · from Reg A Offering (2023) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$8,874,990
Crowd $0 · Private $8.9M · 5 rounds since 2014
Latest share price
$5.00
Reg A Offering (2023) offering price

Financials

FY2022–FY2026 · from SEC filings · hover any figure for its source
$0
−$2.0M
2022
$0
−$2.0M
2023
$0
−$15.4M
2024
$0
−$11.4M
2025
$0
−$16.7M
2026
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 audited
FY2023 audited
FY2024 audited
FY2025 audited
FY2026 audited
Income statement
Revenue
$0
$0
$0
$0
$0
Cost of goods sold
$0
—
—
—
—
Net income
-$1,990,477
-$1,990,000
-$15,426,000
-$11,410,000
-$16,715,000
Taxes paid
—
$0
$0
$0
$0
Balance sheet
Cash
$864,618
$865,000
$8,608,000
$9,136,000
$7,004,000
Accounts receivable
$0
—
—
—
—
Total assets
$864,618
$865,000
$9,407,000
$9,806,000
$7,600,000
Long-term debt
$0
—
—
—
—
Total liabilities
$220,590
$221,000
$1,779,000
$1,707,000
$1,705,000
Other
Headcount
2
—
—
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$61.7M
est. pre-money
Reg A+ · Equity · Jul 2023

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Jun 30, 2026
ClassOutstandingVotes / shareShare of totalLast price
Common stock542,312—100.0%—

Shares outstanding over timein today's share terms

16M8.1M0
Jul 2023Jun 2026
Common stockSplit / conversion

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · Jul 2023Closedvia Digital Offering LLC
Raised $0 / $20MEst. pre-money $61.7M
Raised $2.4MInvestors 27
Raised $675KInvestors 5
Raised $2MInvestors 33
Raised $3.8MInvestors 4

Team

7 people
Lori Bisson
Chief Executive Officer and Director
Dr. Robert Schwartz
Chief Medical Officer
Landy Toth
Chief Technology Officer
Matthew Lourie
Chief Financial Officer
Walter V. Klemp
Executive Chairman
David Robins
Director
Jonathan P. Foster
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 10-QAug 13, 20260001437749-26-027429
    EDGAR
  • Form 10-K/AJun 15, 20260001437749-26-020686
    EDGAR
  • Form 10-KMay 27, 20260001437749-26-018573
    EDGAR
  • Form 10-QFeb 11, 20260001437749-26-003816
    EDGAR
  • Form 10-QNov 12, 20250001437749-25-034517
    EDGAR
  • Form 10-QAug 13, 20250001437749-25-026564
    EDGAR
  • Form 10-K/AJul 28, 20250001437749-25-023669
    EDGAR
  • Form 10-KMay 29, 20250001437749-25-018831
    EDGAR
Source: SEC EDGARCIK 0001617867DEShare price $5.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.